193 related articles for article (PubMed ID: 7000701)
1. Searches among mycobacterial cultures for antileprosy vaccines.
Shepard CC; van Landingham R; Walker LL
Infect Immun; 1980 Sep; 29(3):1034-9. PubMed ID: 7000701
[TBL] [Abstract][Full Text] [Related]
2. Heat stability of Mycobacterium leprae immunogenicity.
Shepard CC; Walker LL; van Landingham R
Infect Immun; 1978 Oct; 22(1):87-93. PubMed ID: 365752
[TBL] [Abstract][Full Text] [Related]
3. rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B.
Gillis TP; Tullius MV; Horwitz MA
Infect Immun; 2014 Sep; 82(9):3900-9. PubMed ID: 25001602
[TBL] [Abstract][Full Text] [Related]
4. Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.
Shepard CC; Van Landingham R; Walker LL
Infect Immun; 1976 Oct; 14(4):919-28. PubMed ID: 11189
[TBL] [Abstract][Full Text] [Related]
5. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
6. Immunological potential of a cultivable mycobacterial strain M. habana against leprosy bacillus in mouse foot pad.
Singh NB; Srivastava ; Gupta HP; Sreevatsa ; Desikan KV
Indian J Lepr; 1985; 57(2):278-81. PubMed ID: 3908575
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of mice against Mycobacterium leprae infection.
Singh NB; Lowe AC; Rees RJ; Colston MJ
Infect Immun; 1989 Feb; 57(2):653-5. PubMed ID: 2643581
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the immunogenicity of vaccines prepared from viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, and a mixture of the two for normal and M. leprae-tolerant mice.
Shepard CC; van Landingham RM; Walker LL; Ye SZ
Infect Immun; 1983 Jun; 40(3):1096-103. PubMed ID: 6343239
[TBL] [Abstract][Full Text] [Related]
9. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):265-73. PubMed ID: 3045224
[TBL] [Abstract][Full Text] [Related]
10. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
[TBL] [Abstract][Full Text] [Related]
11. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
[TBL] [Abstract][Full Text] [Related]
12. Lymphostimulatory and delayed-type hypersensitivity responses to a candidate leprosy vaccine strain: Mycobacterium habana.
Singh NB; Gupta HP; Srivastava A; Kandpal H; Srivastava UM
Lepr Rev; 1997 Jun; 68(2):125-30. PubMed ID: 9217351
[TBL] [Abstract][Full Text] [Related]
13. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.
Black GF; Weir RE; Chaguluka SD; Warndorff D; Crampin AC; Mwaungulu L; Sichali L; Floyd S; Bliss L; Jarman E; Donovan L; Andersen P; Britton W; Hewinson G; Huygen K; Paulsen J; Singh M; Prestidge R; Fine PE; Dockrell HM
Clin Diagn Lab Immunol; 2003 Jul; 10(4):602-11. PubMed ID: 12853392
[TBL] [Abstract][Full Text] [Related]
14. Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with Mycobacterium bovis BCG and Mycobacterium leprae.
Mustafa AS; Lundin KE; Oftung F
Infect Immun; 1993 Dec; 61(12):5294-301. PubMed ID: 8225603
[TBL] [Abstract][Full Text] [Related]
15. Effect of purification steps on the immunogenicity of Mycobacterium leprae.
Shepard CC; Draper P; Rees RJ; Lowe C
Br J Exp Pathol; 1980 Aug; 61(4):376-9. PubMed ID: 7000133
[TBL] [Abstract][Full Text] [Related]
16. DNA encoding a single mycobacterial antigen protects against leprosy infection.
Martin E; Roche PW; Triccas JA; Britton WJ
Vaccine; 2001 Jan; 19(11-12):1391-6. PubMed ID: 11163661
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium bovis BCG but not Mycobacterium leprae induces TNF-alpha secretion in human monocytic THP-1 cells.
Oliveira MM; Charlab R; Pessolani MC
Mem Inst Oswaldo Cruz; 2001 Oct; 96(7):973-8. PubMed ID: 11685264
[TBL] [Abstract][Full Text] [Related]
18. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
Gormus BJ; Meyers WM
Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
[TBL] [Abstract][Full Text] [Related]
19. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
20. [Development of antileprosy vaccines].
Kalianina OV; Iushchenko AA
Zh Mikrobiol Epidemiol Immunobiol; 2005; (2):93-100. PubMed ID: 15881952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
